close

Meridian Bioscience, Inc., a life science company, engages in the development, manufacture, sale, and distribution of diagnostic test kits primarily for respiratory, gastrointestinal, viral, and parasitic infectious diseases. The immunodiagnostic technologies used in its diagnostic test kits include enzyme immunoassay, immunofluorescence, particle agglutination/aggregation, immunodiffusion, complement fixation, and chemical stains used by reference laboratories, hospitals, and physiciansÂ’ offices. The company also manufactures and distributes bulk antigens, antibodies, and reagents used by researchers and other diagnostic manufacturers. In addition, it engages in the contract development and manufacture of proteins and other biologicals for use by biopharmaceutical and biotechnology companies engaged in the research for new drugs and vaccines. Meridian Bioscience markets its products through direct sales force and independent distributors in the United States, Europe, Africa, and the Middle East. The company was founded in 1976 and is based in Cincinnati, Ohio.

(login to add this stock to your watchlist or favorites)

Key Statistics

Closing Price	17.78
Volume	267753
Volume Avg	286528
52 Week High	27.37
52 Week Low	14.81
PE	27.77
PE (group average)	39
EPS Year	0.66
EPS change Q/Q	20%
EPS change Q/Q Yr ago	20%
EPS change Q/Q next Q est	-18.18%
EPS change Y/Y	29.03%
REV change Q/Q	10.19%
REV change Q/Q Yr ago	32.15%
EPS next Q est	0.22
EPS next Y est	0.98
Divident Annual	0.76
Dividend Yield	4.27%